Literature DB >> 23399083

A patient-centric goal in time to blood pressure control from drug therapy initiation.

Song Hee Hong1, Junling Wang, Sunghee Tak.   

Abstract

A time frame in which newly diagnosed hypertensive patients attain blood pressure (BP) goal would guide patients through uncertainty associated with initiating drug therapy for hypertension control. This study estimates time to BP goal resulting from drug therapy initiation among real-world hypertensive patients and identifies factors associated with variations in time to BP goal. The study uses a historical cohort design. Hypertensive patients who had initiated antihypertensive drug therapy between July 1, 2002, and December 31, 2003, were followed up to 12 months until the end of 2004. Electronic medical records from a medical group were linked with pharmacy claims, as well as with medical claims. Survival analyses were used to compare lengths of time needed to reach BP goals. A total of 223 patients from a real world practice setting had initiated antihypertensive drug therapy. The patients took 3.25 months (95% CI: 2.49-4.82) to reach BP goal. The patient-centric time to BP goal was 7.1 weeks longer than those reported in controlled experimental settings. This finding highlights the gap between results of controlled clinical trials and their application to clinical practice, and informs healthcare practitioners of the importance of setting a patient-centric goal in pharmacological treatment of hypertension.
© 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23399083      PMCID: PMC5414534          DOI: 10.1111/cts.12021

Source DB:  PubMed          Journal:  Clin Transl Sci        ISSN: 1752-8054            Impact factor:   4.689


  17 in total

1.  Elevated systolic blood pressure as a risk factor for cardiovascular and renal disease.

Authors:  J He; P K Whelton
Journal:  J Hypertens Suppl       Date:  1999-06

2.  Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.

Authors:  Kenneth A Jamerson; Oliseyenum Nwose; Lisa Jean-Louis; Lesley Schofield; Das Purkayastha; Michelle Baron
Journal:  Am J Hypertens       Date:  2004-06       Impact factor: 2.689

3.  Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention.

Authors:  Clive Rosendorff; Henry R Black; Christopher P Cannon; Bernard J Gersh; Joel Gore; Joseph L Izzo; Norman M Kaplan; Christopher M O'Connor; Patrick T O'Gara; Suzanne Oparil
Journal:  Circulation       Date:  2007-05-14       Impact factor: 29.690

4.  Writing SMART rehabilitation goals and achieving goal attainment scaling: a practical guide.

Authors:  Thamar J H Bovend'Eerdt; Rachel E Botell; Derick T Wade
Journal:  Clin Rehabil       Date:  2009-02-23       Impact factor: 3.477

5.  Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. A cooperative study.

Authors: 
Journal:  JAMA       Date:  1977-01-17       Impact factor: 56.272

6.  Responsiveness of Goal Attainment Scaling in comparison to two standardized measures in outcome evaluation of children with cerebral palsy.

Authors:  Duco Steenbeek; Jan Willem Gorter; Marjolijn Ketelaar; Krys Galama; Eline Lindeman
Journal:  Clin Rehabil       Date:  2011-07-27       Impact factor: 3.477

7.  Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials.

Authors:  Seamus P Whelton; Ashley Chin; Xue Xin; Jiang He
Journal:  Ann Intern Med       Date:  2002-04-02       Impact factor: 25.391

8.  Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

Authors:  Ihab Hajjar; Theodore A Kotchen
Journal:  JAMA       Date:  2003-07-09       Impact factor: 56.272

9.  Achieving BP goals with valsartan and HCTZ alone and in combination: pooled analysis of two randomized, double-blind, placebo-controlled studies.

Authors:  David T Nash; Nora Crikelair; Dion Zappe
Journal:  Curr Med Res Opin       Date:  2008-08-06       Impact factor: 2.580

10.  Cardiovascular disease in patients with schizophrenia in Saskatchewan, Canada.

Authors:  Suellen M Curkendall; Jingping Mo; Dale B Glasser; Mary Rose Stang; Judith K Jones
Journal:  J Clin Psychiatry       Date:  2004-05       Impact factor: 4.384

View more
  2 in total

1.  Antihypertensive medication initiation among young adults with regular primary care use.

Authors:  Heather M Johnson; Carolyn T Thorpe; Christie M Bartels; Jessica R Schumacher; Mari Palta; Nancy Pandhi; Ann M Sheehy; Maureen A Smith
Journal:  J Gen Intern Med       Date:  2014-02-04       Impact factor: 5.128

2.  Time to Initiation of Antihypertensive Therapy After Onset of Elevated Blood Pressure in Patients With Primary Proteinuric Kidney Disease.

Authors:  Donald J Weaver; Anne Waldo; Gia J Oh; Elaine S Kamil; Matthew Elliott; Sharon Adler; Anne Pesenson; Meg M Modes; Patrick Gipson; Richard A Lafayette; David T Selewski; Samara E Attalla; Richard Eikstadt; Jonathan P Troost; Debbie S Gipson; Susan F Massengill
Journal:  Kidney Med       Date:  2020-01-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.